Tilray | TRLY - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Acasti Pharma USD 1.96M 180K 2025-09
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 424K 23K 2026-06
Aurora Cannabis CAD 40.89M 515K 2026-06
Avita Medical AUD 19.54M 516K 2026-06
Canopy Growth CAD 33.99M 2.83M 2026-06
Cronos Group USD 17.59M 237K 2026-06
Dianthus Therapeutics USD 13.56M 1.09M 2026-06
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
IQVIA Holdings USD 569M 5M 2026-09
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Moderna USD 216M 43M 2026-06
Organigram Holdings CAD 26.51M 4.5M 2026-06
Organon & Co USD 407M 27M 2026-09
Revvity USD 275.33M 3.25M 2026-09
Tectonic Therapeutic USD 6.17M 260K 2026-06
Tilray USD 24.85M 1.7M 2025-09
Viatris USD 950.8M 183.7M 2026-09
Xeris Pharmaceuticals USD 61.04M 7.89M 2026-06
Zealand Pharma A/S 104M 12.19M 2026-03